Cite
HARVARD Citation
Daud, A. et al. (2017). Indirect treatment comparison of dabrafenib plus trametinib versus vemurafenib plus cobimetinib in previously untreated metastatic melanoma patients. Journal of hematology & oncology. 10 (1), pp. 1-9. [Online].